nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR2A—Alzheimer's disease	0.272	1	CbGaD
Lurasidone—HTR2A—Donepezil—Alzheimer's disease	0.172	0.415	CbGbCtD
Lurasidone—DRD2—Memantine—Alzheimer's disease	0.138	0.331	CbGbCtD
Lurasidone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0456	0.11	CbGbCtD
Lurasidone—CYP3A4—Donepezil—Alzheimer's disease	0.0365	0.0877	CbGbCtD
Lurasidone—CYP3A4—Galantamine—Alzheimer's disease	0.0235	0.0565	CbGbCtD
Lurasidone—HTR2A—choroid plexus—Alzheimer's disease	0.0082	0.129	CbGeAlD
Lurasidone—HTR7—locus ceruleus—Alzheimer's disease	0.00812	0.128	CbGeAlD
Lurasidone—HTR2A—locus ceruleus—Alzheimer's disease	0.00507	0.0796	CbGeAlD
Lurasidone—HTR2A—cerebellar cortex—Alzheimer's disease	0.00413	0.0649	CbGeAlD
Lurasidone—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00403	0.0633	CbGeAlD
Lurasidone—HTR7—telencephalic ventricle—Alzheimer's disease	0.00385	0.0605	CbGeAlD
Lurasidone—DRD2—telencephalic ventricle—Alzheimer's disease	0.00364	0.0572	CbGeAlD
Lurasidone—HTR2A—telencephalic ventricle—Alzheimer's disease	0.0024	0.0377	CbGeAlD
Lurasidone—HTR7—blood vessel—Alzheimer's disease	0.00191	0.0299	CbGeAlD
Lurasidone—Ziprasidone—HTR6—Alzheimer's disease	0.00189	0.514	CrCbGaD
Lurasidone—HTR2A—blood vessel—Alzheimer's disease	0.00119	0.0187	CbGeAlD
Lurasidone—HTR1A—forebrain—Alzheimer's disease	0.00105	0.0165	CbGeAlD
Lurasidone—HTR7—forebrain—Alzheimer's disease	0.00101	0.0158	CbGeAlD
Lurasidone—HTR1A—telencephalon—Alzheimer's disease	0.000968	0.0152	CbGeAlD
Lurasidone—DRD2—forebrain—Alzheimer's disease	0.000951	0.0149	CbGeAlD
Lurasidone—HTR7—telencephalon—Alzheimer's disease	0.000925	0.0145	CbGeAlD
Lurasidone—DRD2—telencephalon—Alzheimer's disease	0.000875	0.0137	CbGeAlD
Lurasidone—ADRA2C—telencephalon—Alzheimer's disease	0.00085	0.0134	CbGeAlD
Lurasidone—ADRA2A—forebrain—Alzheimer's disease	0.000738	0.0116	CbGeAlD
Lurasidone—Ziprasidone—SLC6A4—Alzheimer's disease	0.000723	0.197	CrCbGaD
Lurasidone—HTR2A—embryo—Alzheimer's disease	0.000709	0.0111	CbGeAlD
Lurasidone—ADRA2A—telencephalon—Alzheimer's disease	0.000678	0.0107	CbGeAlD
Lurasidone—HTR2A—forebrain—Alzheimer's disease	0.000627	0.00985	CbGeAlD
Lurasidone—HTR2A—telencephalon—Alzheimer's disease	0.000577	0.00906	CbGeAlD
Lurasidone—HTR1A—nervous system—Alzheimer's disease	0.000571	0.00897	CbGeAlD
Lurasidone—Ziprasidone—HTR2A—Alzheimer's disease	0.000556	0.151	CrCbGaD
Lurasidone—HTR1A—central nervous system—Alzheimer's disease	0.00055	0.00864	CbGeAlD
Lurasidone—HTR7—nervous system—Alzheimer's disease	0.000546	0.00858	CbGeAlD
Lurasidone—HTR1A—cerebellum—Alzheimer's disease	0.000538	0.00845	CbGeAlD
Lurasidone—HTR7—central nervous system—Alzheimer's disease	0.000526	0.00826	CbGeAlD
Lurasidone—DRD2—nervous system—Alzheimer's disease	0.000516	0.00811	CbGeAlD
Lurasidone—HTR7—cerebellum—Alzheimer's disease	0.000514	0.00807	CbGeAlD
Lurasidone—Ziprasidone—CYP2D6—Alzheimer's disease	0.000508	0.138	CrCbGaD
Lurasidone—ADRA2C—nervous system—Alzheimer's disease	0.000502	0.00788	CbGeAlD
Lurasidone—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.000501	0.00263	CcSEcCtD
Lurasidone—DRD2—central nervous system—Alzheimer's disease	0.000497	0.00781	CbGeAlD
Lurasidone—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000494	0.00259	CcSEcCtD
Lurasidone—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.000491	0.00258	CcSEcCtD
Lurasidone—Psychotic disorder—Memantine—Alzheimer's disease	0.00049	0.00257	CcSEcCtD
Lurasidone—Gastritis—Donepezil—Alzheimer's disease	0.000489	0.00257	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000487	0.00256	CcSEcCtD
Lurasidone—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000487	0.00256	CcSEcCtD
Lurasidone—DRD2—cerebellum—Alzheimer's disease	0.000486	0.00763	CbGeAlD
Lurasidone—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000485	0.00254	CcSEcCtD
Lurasidone—Urethral disorder—Galantamine—Alzheimer's disease	0.000484	0.00254	CcSEcCtD
Lurasidone—ADRA2C—central nervous system—Alzheimer's disease	0.000483	0.00759	CbGeAlD
Lurasidone—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000479	0.00252	CcSEcCtD
Lurasidone—Dysphagia—Donepezil—Alzheimer's disease	0.000478	0.00251	CcSEcCtD
Lurasidone—Influenza—Donepezil—Alzheimer's disease	0.000478	0.00251	CcSEcCtD
Lurasidone—Eosinophilia—Donepezil—Alzheimer's disease	0.000473	0.00248	CcSEcCtD
Lurasidone—ADRA2C—cerebellum—Alzheimer's disease	0.000472	0.00742	CbGeAlD
Lurasidone—Blood creatinine increased—Memantine—Alzheimer's disease	0.00047	0.00247	CcSEcCtD
Lurasidone—Angina pectoris—Donepezil—Alzheimer's disease	0.000465	0.00244	CcSEcCtD
Lurasidone—Eye disorder—Galantamine—Alzheimer's disease	0.000461	0.00242	CcSEcCtD
Lurasidone—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000458	0.0024	CcSEcCtD
Lurasidone—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000458	0.0024	CcSEcCtD
Lurasidone—Cardiac disorder—Galantamine—Alzheimer's disease	0.000458	0.0024	CcSEcCtD
Lurasidone—Nasopharyngitis—Memantine—Alzheimer's disease	0.000449	0.00235	CcSEcCtD
Lurasidone—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000448	0.00235	CcSEcCtD
Lurasidone—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000448	0.00235	CcSEcCtD
Lurasidone—Angiopathy—Galantamine—Alzheimer's disease	0.000448	0.00235	CcSEcCtD
Lurasidone—Dysuria—Donepezil—Alzheimer's disease	0.000447	0.00234	CcSEcCtD
Lurasidone—Gastritis—Memantine—Alzheimer's disease	0.000444	0.00233	CcSEcCtD
Lurasidone—Breast disorder—Rivastigmine—Alzheimer's disease	0.000444	0.00233	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000443	0.00232	CcSEcCtD
Lurasidone—Arrhythmia—Galantamine—Alzheimer's disease	0.000441	0.00231	CcSEcCtD
Lurasidone—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000439	0.0023	CcSEcCtD
Lurasidone—HTR1A—brain—Alzheimer's disease	0.000437	0.00686	CbGeAlD
Lurasidone—Weight increased—Donepezil—Alzheimer's disease	0.000435	0.00228	CcSEcCtD
Lurasidone—Gastritis—Rivastigmine—Alzheimer's disease	0.000434	0.00228	CcSEcCtD
Lurasidone—Influenza—Memantine—Alzheimer's disease	0.000434	0.00228	CcSEcCtD
Lurasidone—Dysphagia—Memantine—Alzheimer's disease	0.000434	0.00228	CcSEcCtD
Lurasidone—Mental disorder—Galantamine—Alzheimer's disease	0.000432	0.00227	CcSEcCtD
Lurasidone—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000431	0.00226	CcSEcCtD
Lurasidone—Malnutrition—Galantamine—Alzheimer's disease	0.000429	0.00225	CcSEcCtD
Lurasidone—Infestation NOS—Donepezil—Alzheimer's disease	0.000426	0.00223	CcSEcCtD
Lurasidone—Infestation—Donepezil—Alzheimer's disease	0.000426	0.00223	CcSEcCtD
Lurasidone—Dysphagia—Rivastigmine—Alzheimer's disease	0.000424	0.00223	CcSEcCtD
Lurasidone—Flatulence—Galantamine—Alzheimer's disease	0.000423	0.00222	CcSEcCtD
Lurasidone—Angina pectoris—Memantine—Alzheimer's disease	0.000422	0.00222	CcSEcCtD
Lurasidone—Renal failure—Donepezil—Alzheimer's disease	0.000419	0.0022	CcSEcCtD
Lurasidone—HTR7—brain—Alzheimer's disease	0.000417	0.00656	CbGeAlD
Lurasidone—Back pain—Galantamine—Alzheimer's disease	0.000415	0.00218	CcSEcCtD
Lurasidone—Urinary tract infection—Donepezil—Alzheimer's disease	0.000414	0.00217	CcSEcCtD
Lurasidone—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000413	0.00217	CcSEcCtD
Lurasidone—Muscle spasms—Galantamine—Alzheimer's disease	0.000413	0.00217	CcSEcCtD
Lurasidone—Neutropenia—Memantine—Alzheimer's disease	0.000405	0.00213	CcSEcCtD
Lurasidone—Dysuria—Memantine—Alzheimer's disease	0.000405	0.00213	CcSEcCtD
Lurasidone—Vision blurred—Galantamine—Alzheimer's disease	0.000405	0.00212	CcSEcCtD
Lurasidone—Tremor—Galantamine—Alzheimer's disease	0.000402	0.00211	CcSEcCtD
Lurasidone—ADRA2A—nervous system—Alzheimer's disease	0.000401	0.00629	CbGeAlD
Lurasidone—Erectile dysfunction—Memantine—Alzheimer's disease	0.000399	0.0021	CcSEcCtD
Lurasidone—Anaemia—Galantamine—Alzheimer's disease	0.000397	0.00208	CcSEcCtD
Lurasidone—Dysuria—Rivastigmine—Alzheimer's disease	0.000397	0.00208	CcSEcCtD
Lurasidone—DRD2—brain—Alzheimer's disease	0.000395	0.0062	CbGeAlD
Lurasidone—Weight increased—Memantine—Alzheimer's disease	0.000395	0.00207	CcSEcCtD
Lurasidone—Agitation—Galantamine—Alzheimer's disease	0.000395	0.00207	CcSEcCtD
Lurasidone—Hyperglycaemia—Memantine—Alzheimer's disease	0.000391	0.00205	CcSEcCtD
Lurasidone—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000391	0.00205	CcSEcCtD
Lurasidone—Bradycardia—Donepezil—Alzheimer's disease	0.000389	0.00204	CcSEcCtD
Lurasidone—Malaise—Galantamine—Alzheimer's disease	0.000387	0.00203	CcSEcCtD
Lurasidone—Infestation NOS—Memantine—Alzheimer's disease	0.000387	0.00203	CcSEcCtD
Lurasidone—Infestation—Memantine—Alzheimer's disease	0.000387	0.00203	CcSEcCtD
Lurasidone—Weight increased—Rivastigmine—Alzheimer's disease	0.000386	0.00203	CcSEcCtD
Lurasidone—Vertigo—Galantamine—Alzheimer's disease	0.000386	0.00202	CcSEcCtD
Lurasidone—ADRA2A—central nervous system—Alzheimer's disease	0.000386	0.00606	CbGeAlD
Lurasidone—Syncope—Galantamine—Alzheimer's disease	0.000385	0.00202	CcSEcCtD
Lurasidone—ADRA2C—brain—Alzheimer's disease	0.000384	0.00603	CbGeAlD
Lurasidone—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000383	0.00201	CcSEcCtD
Lurasidone—Renal failure—Memantine—Alzheimer's disease	0.00038	0.00199	CcSEcCtD
Lurasidone—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000378	0.00198	CcSEcCtD
Lurasidone—Infestation—Rivastigmine—Alzheimer's disease	0.000378	0.00198	CcSEcCtD
Lurasidone—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000378	0.00198	CcSEcCtD
Lurasidone—Loss of consciousness—Galantamine—Alzheimer's disease	0.000377	0.00198	CcSEcCtD
Lurasidone—ADRA2A—cerebellum—Alzheimer's disease	0.000377	0.00592	CbGeAlD
Lurasidone—Urinary tract infection—Memantine—Alzheimer's disease	0.000376	0.00197	CcSEcCtD
Lurasidone—Urethral disorder—Donepezil—Alzheimer's disease	0.000375	0.00197	CcSEcCtD
Lurasidone—Convulsion—Galantamine—Alzheimer's disease	0.000372	0.00195	CcSEcCtD
Lurasidone—Renal failure—Rivastigmine—Alzheimer's disease	0.000372	0.00195	CcSEcCtD
Lurasidone—Hypertension—Galantamine—Alzheimer's disease	0.000371	0.00195	CcSEcCtD
Lurasidone—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000368	0.00193	CcSEcCtD
Lurasidone—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000366	0.00192	CcSEcCtD
Lurasidone—Myalgia—Galantamine—Alzheimer's disease	0.000366	0.00192	CcSEcCtD
Lurasidone—Anxiety—Galantamine—Alzheimer's disease	0.000364	0.00191	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000363	0.00191	CcSEcCtD
Lurasidone—Agranulocytosis—Memantine—Alzheimer's disease	0.000361	0.00189	CcSEcCtD
Lurasidone—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000358	0.00188	CcSEcCtD
Lurasidone—Dry mouth—Galantamine—Alzheimer's disease	0.000358	0.00188	CcSEcCtD
Lurasidone—Bradycardia—Memantine—Alzheimer's disease	0.000353	0.00185	CcSEcCtD
Lurasidone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000346	0.00181	CcSEcCtD
Lurasidone—Shock—Galantamine—Alzheimer's disease	0.000345	0.00181	CcSEcCtD
Lurasidone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000344	0.0018	CcSEcCtD
Lurasidone—Urinary tract disorder—Memantine—Alzheimer's disease	0.000343	0.0018	CcSEcCtD
Lurasidone—Tachycardia—Galantamine—Alzheimer's disease	0.000342	0.00179	CcSEcCtD
Lurasidone—Arrhythmia—Donepezil—Alzheimer's disease	0.000341	0.00179	CcSEcCtD
Lurasidone—Connective tissue disorder—Memantine—Alzheimer's disease	0.000341	0.00179	CcSEcCtD
Lurasidone—HTR2A—nervous system—Alzheimer's disease	0.000341	0.00535	CbGeAlD
Lurasidone—Skin disorder—Galantamine—Alzheimer's disease	0.00034	0.00179	CcSEcCtD
Lurasidone—Urethral disorder—Memantine—Alzheimer's disease	0.00034	0.00179	CcSEcCtD
Lurasidone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000339	0.00178	CcSEcCtD
Lurasidone—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000335	0.00176	CcSEcCtD
Lurasidone—Mental disorder—Donepezil—Alzheimer's disease	0.000335	0.00176	CcSEcCtD
Lurasidone—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000334	0.00175	CcSEcCtD
Lurasidone—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000333	0.00175	CcSEcCtD
Lurasidone—Malnutrition—Donepezil—Alzheimer's disease	0.000333	0.00175	CcSEcCtD
Lurasidone—Flatulence—Donepezil—Alzheimer's disease	0.000328	0.00172	CcSEcCtD
Lurasidone—HTR2A—central nervous system—Alzheimer's disease	0.000328	0.00515	CbGeAlD
Lurasidone—Hypotension—Galantamine—Alzheimer's disease	0.000327	0.00172	CcSEcCtD
Lurasidone—Eye disorder—Memantine—Alzheimer's disease	0.000324	0.0017	CcSEcCtD
Lurasidone—Cardiac disorder—Memantine—Alzheimer's disease	0.000322	0.00169	CcSEcCtD
Lurasidone—Back pain—Donepezil—Alzheimer's disease	0.000322	0.00169	CcSEcCtD
Lurasidone—HTR2A—cerebellum—Alzheimer's disease	0.00032	0.00503	CbGeAlD
Lurasidone—Muscle spasms—Donepezil—Alzheimer's disease	0.00032	0.00168	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000319	0.00168	CcSEcCtD
Lurasidone—Eye disorder—Rivastigmine—Alzheimer's disease	0.000317	0.00167	CcSEcCtD
Lurasidone—Insomnia—Galantamine—Alzheimer's disease	0.000317	0.00166	CcSEcCtD
Lurasidone—CYP3A4—nervous system—Alzheimer's disease	0.000315	0.00495	CbGeAlD
Lurasidone—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000315	0.00165	CcSEcCtD
Lurasidone—Angiopathy—Memantine—Alzheimer's disease	0.000315	0.00165	CcSEcCtD
Lurasidone—Vision blurred—Donepezil—Alzheimer's disease	0.000314	0.00165	CcSEcCtD
Lurasidone—Tremor—Donepezil—Alzheimer's disease	0.000312	0.00164	CcSEcCtD
Lurasidone—Somnolence—Galantamine—Alzheimer's disease	0.000312	0.00163	CcSEcCtD
Lurasidone—Arrhythmia—Memantine—Alzheimer's disease	0.00031	0.00163	CcSEcCtD
Lurasidone—Dyspepsia—Galantamine—Alzheimer's disease	0.000308	0.00162	CcSEcCtD
Lurasidone—Angiopathy—Rivastigmine—Alzheimer's disease	0.000308	0.00162	CcSEcCtD
Lurasidone—Anaemia—Donepezil—Alzheimer's disease	0.000308	0.00161	CcSEcCtD
Lurasidone—ADRA2A—brain—Alzheimer's disease	0.000306	0.00481	CbGeAlD
Lurasidone—Agitation—Donepezil—Alzheimer's disease	0.000306	0.0016	CcSEcCtD
Lurasidone—Decreased appetite—Galantamine—Alzheimer's disease	0.000305	0.0016	CcSEcCtD
Lurasidone—Mental disorder—Memantine—Alzheimer's disease	0.000304	0.0016	CcSEcCtD
Lurasidone—CYP3A4—central nervous system—Alzheimer's disease	0.000304	0.00477	CbGeAlD
Lurasidone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000303	0.00159	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000303	0.00159	CcSEcCtD
Lurasidone—Malnutrition—Memantine—Alzheimer's disease	0.000302	0.00159	CcSEcCtD
Lurasidone—Fatigue—Galantamine—Alzheimer's disease	0.000302	0.00159	CcSEcCtD
Lurasidone—Malaise—Donepezil—Alzheimer's disease	0.0003	0.00157	CcSEcCtD
Lurasidone—Vertigo—Donepezil—Alzheimer's disease	0.000299	0.00157	CcSEcCtD
Lurasidone—Syncope—Donepezil—Alzheimer's disease	0.000298	0.00157	CcSEcCtD
Lurasidone—Flatulence—Memantine—Alzheimer's disease	0.000298	0.00156	CcSEcCtD
Lurasidone—Mental disorder—Rivastigmine—Alzheimer's disease	0.000297	0.00156	CcSEcCtD
Lurasidone—Malnutrition—Rivastigmine—Alzheimer's disease	0.000296	0.00155	CcSEcCtD
Lurasidone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000292	0.00153	CcSEcCtD
Lurasidone—Back pain—Memantine—Alzheimer's disease	0.000292	0.00153	CcSEcCtD
Lurasidone—Flatulence—Rivastigmine—Alzheimer's disease	0.000291	0.00153	CcSEcCtD
Lurasidone—Convulsion—Donepezil—Alzheimer's disease	0.000288	0.00151	CcSEcCtD
Lurasidone—Hypertension—Donepezil—Alzheimer's disease	0.000287	0.00151	CcSEcCtD
Lurasidone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000287	0.0015	CcSEcCtD
Lurasidone—Back pain—Rivastigmine—Alzheimer's disease	0.000286	0.0015	CcSEcCtD
Lurasidone—Vision blurred—Memantine—Alzheimer's disease	0.000285	0.00149	CcSEcCtD
Lurasidone—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000284	0.00149	CcSEcCtD
Lurasidone—Myalgia—Donepezil—Alzheimer's disease	0.000283	0.00149	CcSEcCtD
Lurasidone—Tremor—Memantine—Alzheimer's disease	0.000283	0.00149	CcSEcCtD
Lurasidone—Anxiety—Donepezil—Alzheimer's disease	0.000282	0.00148	CcSEcCtD
Lurasidone—Anaemia—Memantine—Alzheimer's disease	0.000279	0.00147	CcSEcCtD
Lurasidone—Vision blurred—Rivastigmine—Alzheimer's disease	0.000279	0.00146	CcSEcCtD
Lurasidone—Agitation—Memantine—Alzheimer's disease	0.000278	0.00146	CcSEcCtD
Lurasidone—Dry mouth—Donepezil—Alzheimer's disease	0.000277	0.00145	CcSEcCtD
Lurasidone—Abdominal pain—Galantamine—Alzheimer's disease	0.000277	0.00145	CcSEcCtD
Lurasidone—Tremor—Rivastigmine—Alzheimer's disease	0.000277	0.00145	CcSEcCtD
Lurasidone—Anaemia—Rivastigmine—Alzheimer's disease	0.000273	0.00143	CcSEcCtD
Lurasidone—Malaise—Memantine—Alzheimer's disease	0.000272	0.00143	CcSEcCtD
Lurasidone—Agitation—Rivastigmine—Alzheimer's disease	0.000272	0.00143	CcSEcCtD
Lurasidone—Vertigo—Memantine—Alzheimer's disease	0.000271	0.00142	CcSEcCtD
Lurasidone—Syncope—Memantine—Alzheimer's disease	0.000271	0.00142	CcSEcCtD
Lurasidone—Leukopenia—Memantine—Alzheimer's disease	0.00027	0.00142	CcSEcCtD
Lurasidone—Infection—Donepezil—Alzheimer's disease	0.00027	0.00142	CcSEcCtD
Lurasidone—Shock—Donepezil—Alzheimer's disease	0.000267	0.0014	CcSEcCtD
Lurasidone—Malaise—Rivastigmine—Alzheimer's disease	0.000267	0.0014	CcSEcCtD
Lurasidone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000266	0.0014	CcSEcCtD
Lurasidone—Vertigo—Rivastigmine—Alzheimer's disease	0.000266	0.00139	CcSEcCtD
Lurasidone—Loss of consciousness—Memantine—Alzheimer's disease	0.000266	0.00139	CcSEcCtD
Lurasidone—Syncope—Rivastigmine—Alzheimer's disease	0.000265	0.00139	CcSEcCtD
Lurasidone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000263	0.00138	CcSEcCtD
Lurasidone—Convulsion—Memantine—Alzheimer's disease	0.000262	0.00137	CcSEcCtD
Lurasidone—Hypertension—Memantine—Alzheimer's disease	0.000261	0.00137	CcSEcCtD
Lurasidone—HTR2A—brain—Alzheimer's disease	0.00026	0.00409	CbGeAlD
Lurasidone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00026	0.00136	CcSEcCtD
Lurasidone—Myalgia—Memantine—Alzheimer's disease	0.000257	0.00135	CcSEcCtD
Lurasidone—Anxiety—Memantine—Alzheimer's disease	0.000256	0.00135	CcSEcCtD
Lurasidone—Convulsion—Rivastigmine—Alzheimer's disease	0.000256	0.00134	CcSEcCtD
Lurasidone—Hypertension—Rivastigmine—Alzheimer's disease	0.000255	0.00134	CcSEcCtD
Lurasidone—Hypotension—Donepezil—Alzheimer's disease	0.000254	0.00133	CcSEcCtD
Lurasidone—Myalgia—Rivastigmine—Alzheimer's disease	0.000252	0.00132	CcSEcCtD
Lurasidone—Dry mouth—Memantine—Alzheimer's disease	0.000252	0.00132	CcSEcCtD
Lurasidone—Asthenia—Galantamine—Alzheimer's disease	0.000251	0.00132	CcSEcCtD
Lurasidone—Anxiety—Rivastigmine—Alzheimer's disease	0.000251	0.00132	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00025	0.00131	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000247	0.0013	CcSEcCtD
Lurasidone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000246	0.00129	CcSEcCtD
Lurasidone—Insomnia—Donepezil—Alzheimer's disease	0.000246	0.00129	CcSEcCtD
Lurasidone—Infection—Memantine—Alzheimer's disease	0.000245	0.00129	CcSEcCtD
Lurasidone—Shock—Memantine—Alzheimer's disease	0.000243	0.00127	CcSEcCtD
Lurasidone—Dyspnoea—Donepezil—Alzheimer's disease	0.000242	0.00127	CcSEcCtD
Lurasidone—Nervous system disorder—Memantine—Alzheimer's disease	0.000242	0.00127	CcSEcCtD
Lurasidone—Somnolence—Donepezil—Alzheimer's disease	0.000241	0.00127	CcSEcCtD
Lurasidone—Tachycardia—Memantine—Alzheimer's disease	0.000241	0.00126	CcSEcCtD
Lurasidone—Diarrhoea—Galantamine—Alzheimer's disease	0.00024	0.00126	CcSEcCtD
Lurasidone—Infection—Rivastigmine—Alzheimer's disease	0.00024	0.00126	CcSEcCtD
Lurasidone—Skin disorder—Memantine—Alzheimer's disease	0.00024	0.00126	CcSEcCtD
Lurasidone—Dyspepsia—Donepezil—Alzheimer's disease	0.000239	0.00125	CcSEcCtD
Lurasidone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000238	0.00125	CcSEcCtD
Lurasidone—Shock—Rivastigmine—Alzheimer's disease	0.000237	0.00125	CcSEcCtD
Lurasidone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000237	0.00124	CcSEcCtD
Lurasidone—Decreased appetite—Donepezil—Alzheimer's disease	0.000236	0.00124	CcSEcCtD
Lurasidone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000235	0.00124	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000234	0.00123	CcSEcCtD
Lurasidone—Skin disorder—Rivastigmine—Alzheimer's disease	0.000234	0.00123	CcSEcCtD
Lurasidone—Fatigue—Donepezil—Alzheimer's disease	0.000234	0.00123	CcSEcCtD
Lurasidone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000233	0.00122	CcSEcCtD
Lurasidone—Dizziness—Galantamine—Alzheimer's disease	0.000232	0.00122	CcSEcCtD
Lurasidone—Hypotension—Memantine—Alzheimer's disease	0.00023	0.00121	CcSEcCtD
Lurasidone—Hypotension—Rivastigmine—Alzheimer's disease	0.000225	0.00118	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000225	0.00118	CcSEcCtD
Lurasidone—Insomnia—Memantine—Alzheimer's disease	0.000223	0.00117	CcSEcCtD
Lurasidone—Vomiting—Galantamine—Alzheimer's disease	0.000223	0.00117	CcSEcCtD
Lurasidone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000222	0.00117	CcSEcCtD
Lurasidone—Rash—Galantamine—Alzheimer's disease	0.000221	0.00116	CcSEcCtD
Lurasidone—Dermatitis—Galantamine—Alzheimer's disease	0.000221	0.00116	CcSEcCtD
Lurasidone—Dyspnoea—Memantine—Alzheimer's disease	0.00022	0.00115	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00022	0.00115	CcSEcCtD
Lurasidone—Somnolence—Memantine—Alzheimer's disease	0.000219	0.00115	CcSEcCtD
Lurasidone—Insomnia—Rivastigmine—Alzheimer's disease	0.000218	0.00114	CcSEcCtD
Lurasidone—Dyspepsia—Memantine—Alzheimer's disease	0.000217	0.00114	CcSEcCtD
Lurasidone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000215	0.00113	CcSEcCtD
Lurasidone—Abdominal pain—Donepezil—Alzheimer's disease	0.000215	0.00113	CcSEcCtD
Lurasidone—Somnolence—Rivastigmine—Alzheimer's disease	0.000214	0.00113	CcSEcCtD
Lurasidone—Decreased appetite—Memantine—Alzheimer's disease	0.000214	0.00112	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000213	0.00112	CcSEcCtD
Lurasidone—Fatigue—Memantine—Alzheimer's disease	0.000213	0.00112	CcSEcCtD
Lurasidone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000212	0.00111	CcSEcCtD
Lurasidone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00021	0.0011	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000208	0.00109	CcSEcCtD
Lurasidone—Nausea—Galantamine—Alzheimer's disease	0.000208	0.00109	CcSEcCtD
Lurasidone—Fatigue—Rivastigmine—Alzheimer's disease	0.000208	0.00109	CcSEcCtD
Lurasidone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000202	0.00106	CcSEcCtD
Lurasidone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000197	0.00104	CcSEcCtD
Lurasidone—Abdominal pain—Memantine—Alzheimer's disease	0.000195	0.00102	CcSEcCtD
Lurasidone—Asthenia—Donepezil—Alzheimer's disease	0.000195	0.00102	CcSEcCtD
Lurasidone—Pruritus—Donepezil—Alzheimer's disease	0.000192	0.00101	CcSEcCtD
Lurasidone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000191	0.001	CcSEcCtD
Lurasidone—Diarrhoea—Donepezil—Alzheimer's disease	0.000186	0.000975	CcSEcCtD
Lurasidone—Dizziness—Donepezil—Alzheimer's disease	0.00018	0.000942	CcSEcCtD
Lurasidone—Asthenia—Memantine—Alzheimer's disease	0.000177	0.000928	CcSEcCtD
Lurasidone—Pruritus—Memantine—Alzheimer's disease	0.000174	0.000916	CcSEcCtD
Lurasidone—Asthenia—Rivastigmine—Alzheimer's disease	0.000173	0.000908	CcSEcCtD
Lurasidone—Vomiting—Donepezil—Alzheimer's disease	0.000173	0.000906	CcSEcCtD
Lurasidone—Rash—Donepezil—Alzheimer's disease	0.000171	0.000899	CcSEcCtD
Lurasidone—Dermatitis—Donepezil—Alzheimer's disease	0.000171	0.000898	CcSEcCtD
Lurasidone—Pruritus—Rivastigmine—Alzheimer's disease	0.000171	0.000896	CcSEcCtD
Lurasidone—Diarrhoea—Memantine—Alzheimer's disease	0.000169	0.000885	CcSEcCtD
Lurasidone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000165	0.000866	CcSEcCtD
Lurasidone—Dizziness—Memantine—Alzheimer's disease	0.000163	0.000856	CcSEcCtD
Lurasidone—Nausea—Donepezil—Alzheimer's disease	0.000161	0.000847	CcSEcCtD
Lurasidone—Dizziness—Rivastigmine—Alzheimer's disease	0.00016	0.000837	CcSEcCtD
Lurasidone—Vomiting—Memantine—Alzheimer's disease	0.000157	0.000823	CcSEcCtD
Lurasidone—Rash—Memantine—Alzheimer's disease	0.000155	0.000816	CcSEcCtD
Lurasidone—Dermatitis—Memantine—Alzheimer's disease	0.000155	0.000815	CcSEcCtD
Lurasidone—Vomiting—Rivastigmine—Alzheimer's disease	0.000153	0.000805	CcSEcCtD
Lurasidone—Rash—Rivastigmine—Alzheimer's disease	0.000152	0.000798	CcSEcCtD
Lurasidone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000152	0.000797	CcSEcCtD
Lurasidone—Nausea—Memantine—Alzheimer's disease	0.000146	0.000769	CcSEcCtD
Lurasidone—Nausea—Rivastigmine—Alzheimer's disease	0.000143	0.000752	CcSEcCtD
Lurasidone—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	1.03e-05	0.000188	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	1.03e-05	0.000188	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	1.03e-05	0.000188	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CAV1—Alzheimer's disease	1.03e-05	0.000188	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	1.02e-05	0.000188	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	1.02e-05	0.000187	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—S100B—Alzheimer's disease	1e-05	0.000184	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	1e-05	0.000184	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—ESR1—Alzheimer's disease	9.89e-06	0.000181	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	9.88e-06	0.000181	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NGFR—Alzheimer's disease	9.86e-06	0.000181	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CREB1—Alzheimer's disease	9.8e-06	0.000179	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—F2—Alzheimer's disease	9.77e-06	0.000179	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NGFR—Alzheimer's disease	9.7e-06	0.000178	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CREB1—Alzheimer's disease	9.64e-06	0.000177	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADAM10—Alzheimer's disease	9.63e-06	0.000176	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	9.63e-06	0.000176	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	9.6e-06	0.000176	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CCL2—Alzheimer's disease	9.59e-06	0.000176	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NOTCH1—Alzheimer's disease	9.56e-06	0.000175	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IGF2—Alzheimer's disease	9.56e-06	0.000175	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	9.55e-06	0.000175	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—MTHFR—Alzheimer's disease	9.54e-06	0.000175	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADAM10—Alzheimer's disease	9.48e-06	0.000174	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	9.46e-06	0.000173	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	9.45e-06	0.000173	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CCL2—Alzheimer's disease	9.43e-06	0.000173	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	9.41e-06	0.000172	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IGF1R—Alzheimer's disease	9.24e-06	0.000169	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	9.16e-06	0.000168	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—S100B—Alzheimer's disease	9.11e-06	0.000167	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	9.07e-06	0.000166	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—GSK3B—Alzheimer's disease	8.97e-06	0.000164	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—S100B—Alzheimer's disease	8.96e-06	0.000164	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—TP53—Alzheimer's disease	8.93e-06	0.000164	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CALM1—Alzheimer's disease	8.91e-06	0.000163	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	8.9e-06	0.000163	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CREB1—Alzheimer's disease	8.9e-06	0.000163	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—APOE—Alzheimer's disease	8.88e-06	0.000163	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—LPL—Alzheimer's disease	8.86e-06	0.000162	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—INS—Alzheimer's disease	8.85e-06	0.000162	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	8.83e-06	0.000162	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	8.81e-06	0.000161	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CAV1—Alzheimer's disease	8.8e-06	0.000161	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MEF2C—Alzheimer's disease	8.78e-06	0.000161	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	8.77e-06	0.000161	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CCL2—Alzheimer's disease	8.71e-06	0.000159	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	8.67e-06	0.000159	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	8.67e-06	0.000159	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	8.62e-06	0.000158	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PRKCG—Alzheimer's disease	8.61e-06	0.000158	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—LPL—Alzheimer's disease	8.61e-06	0.000158	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	8.58e-06	0.000157	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IGF1—Alzheimer's disease	8.56e-06	0.000157	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	8.53e-06	0.000156	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	8.44e-06	0.000154	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NGF—Alzheimer's disease	8.39e-06	0.000154	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	8.39e-06	0.000154	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	8.26e-06	0.000151	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	8.25e-06	0.000151	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCR5—Alzheimer's disease	8.16e-06	0.000149	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	8.15e-06	0.000149	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—LPL—Alzheimer's disease	8.04e-06	0.000147	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR2A—Alzheimer's disease	7.99e-06	0.000146	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	7.97e-06	0.000146	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	7.91e-06	0.000145	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	7.84e-06	0.000144	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	7.82e-06	0.000143	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	7.76e-06	0.000142	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NOS3—Alzheimer's disease	7.76e-06	0.000142	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	7.75e-06	0.000142	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PPARG—Alzheimer's disease	7.74e-06	0.000142	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	7.7e-06	0.000141	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	7.69e-06	0.000141	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	7.67e-06	0.000141	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	7.67e-06	0.000141	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NGF—Alzheimer's disease	7.61e-06	0.000139	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	7.6e-06	0.000139	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—INS—Alzheimer's disease	7.59e-06	0.000139	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.56e-06	0.000138	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.56e-06	0.000138	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—AKT1—Alzheimer's disease	7.54e-06	0.000138	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	7.51e-06	0.000137	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	7.49e-06	0.000137	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CALM1—Alzheimer's disease	7.45e-06	0.000136	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—APOE—Alzheimer's disease	7.43e-06	0.000136	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—LEP—Alzheimer's disease	7.43e-06	0.000136	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	7.41e-06	0.000136	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CAV1—Alzheimer's disease	7.36e-06	0.000135	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	7.33e-06	0.000134	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	7.29e-06	0.000133	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—TP53—Alzheimer's disease	7.26e-06	0.000133	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.25e-06	0.000133	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	7.25e-06	0.000133	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CALM1—Alzheimer's disease	7.24e-06	0.000133	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—F2—Alzheimer's disease	7.24e-06	0.000133	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—APOE—Alzheimer's disease	7.21e-06	0.000132	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	7.2e-06	0.000132	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CAV1—Alzheimer's disease	7.15e-06	0.000131	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	7.13e-06	0.000131	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—ESR1—Alzheimer's disease	7.09e-06	0.00013	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	7.08e-06	0.00013	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—F2—Alzheimer's disease	7e-06	0.000128	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	7e-06	0.000128	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	6.98e-06	0.000128	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	6.85e-06	0.000126	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	6.82e-06	0.000125	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	6.76e-06	0.000124	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—A2M—Alzheimer's disease	6.74e-06	0.000123	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—APOE—Alzheimer's disease	6.74e-06	0.000123	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—LEP—Alzheimer's disease	6.74e-06	0.000123	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	6.68e-06	0.000122	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—NOS3—Alzheimer's disease	6.65e-06	0.000122	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	6.65e-06	0.000122	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—AKT1—Alzheimer's disease	6.65e-06	0.000122	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	6.65e-06	0.000122	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	6.63e-06	0.000121	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	6.63e-06	0.000121	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	6.63e-06	0.000121	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	6.59e-06	0.000121	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CASP3—Alzheimer's disease	6.59e-06	0.000121	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	6.57e-06	0.00012	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—INS—Alzheimer's disease	6.56e-06	0.00012	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL6—Alzheimer's disease	6.54e-06	0.00012	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	6.49e-06	0.000119	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	6.45e-06	0.000118	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	6.43e-06	0.000118	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	6.43e-06	0.000118	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	6.38e-06	0.000117	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—F2—Alzheimer's disease	6.35e-06	0.000116	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	6.34e-06	0.000116	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	6.34e-06	0.000116	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	6.33e-06	0.000116	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PPARG—Alzheimer's disease	6.28e-06	0.000115	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—F2—Alzheimer's disease	6.25e-06	0.000115	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	6.24e-06	0.000114	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.22e-06	0.000114	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—INS—Alzheimer's disease	6.16e-06	0.000113	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	6.14e-06	0.000112	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	6.13e-06	0.000112	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	6.12e-06	0.000112	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	6.09e-06	0.000111	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MAPK8—Alzheimer's disease	6.05e-06	0.000111	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	6.05e-06	0.000111	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—AKT1—Alzheimer's disease	6.04e-06	0.000111	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	6.03e-06	0.00011	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	6.03e-06	0.00011	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	5.98e-06	0.000109	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.86e-06	0.000107	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	5.84e-06	0.000107	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.8e-06	0.000106	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	5.79e-06	0.000106	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	5.76e-06	0.000105	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—INS—Alzheimer's disease	5.76e-06	0.000105	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	5.75e-06	0.000105	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	5.74e-06	0.000105	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	5.7e-06	0.000104	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	5.69e-06	0.000104	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—INS—Alzheimer's disease	5.66e-06	0.000104	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	5.66e-06	0.000104	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	5.59e-06	0.000102	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	5.57e-06	0.000102	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	5.57e-06	0.000102	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.57e-06	0.000102	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	5.56e-06	0.000102	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.5e-06	0.000101	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.5e-06	0.000101	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	5.48e-06	0.0001	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—NOS3—Alzheimer's disease	5.4e-06	9.9e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.39e-06	9.87e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	5.22e-06	9.57e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	5.18e-06	9.49e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	5.15e-06	9.44e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	5.13e-06	9.4e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.11e-06	9.36e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	5.07e-06	9.28e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	5.05e-06	9.24e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	4.98e-06	9.13e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	4.97e-06	9.1e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	4.94e-06	9.05e-05	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.93e-06	9.02e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	4.88e-06	8.94e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	4.85e-06	8.88e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.82e-06	8.83e-05	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	4.77e-06	8.73e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	4.72e-06	8.65e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	4.69e-06	8.59e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.67e-06	8.56e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	4.52e-06	8.28e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	4.49e-06	8.22e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	4.47e-06	8.19e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	4.34e-06	7.95e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	4.33e-06	7.93e-05	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.33e-06	7.92e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	4.29e-06	7.85e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	4.26e-06	7.8e-05	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.26e-06	7.79e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TP53—Alzheimer's disease	4.22e-06	7.73e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	4.22e-06	7.72e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	4.19e-06	7.67e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	4.14e-06	7.59e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.03e-06	7.37e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.01e-06	7.34e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	4.01e-06	7.34e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	3.94e-06	7.21e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	3.93e-06	7.19e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	3.88e-06	7.1e-05	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.87e-06	7.09e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6—Alzheimer's disease	3.87e-06	7.08e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	3.87e-06	7.08e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	3.84e-06	7.03e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	3.81e-06	6.98e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	3.8e-06	6.96e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	3.68e-06	6.74e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.67e-06	6.71e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	3.64e-06	6.66e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	3.58e-06	6.55e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	3.57e-06	6.53e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	3.53e-06	6.46e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	3.52e-06	6.44e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	3.34e-06	6.11e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.3e-06	6.05e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	3.28e-06	6.01e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	3.26e-06	5.96e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	3.13e-06	5.73e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.08e-06	5.65e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.07e-06	5.63e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—AKT1—Alzheimer's disease	3.06e-06	5.6e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.05e-06	5.58e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	3.03e-06	5.55e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.99e-06	5.47e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	2.86e-06	5.25e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	2.77e-06	5.08e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TP53—Alzheimer's disease	2.75e-06	5.03e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	2.7e-06	4.95e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.68e-06	4.9e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	2.64e-06	4.84e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—INS—Alzheimer's disease	2.63e-06	4.81e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	2.56e-06	4.68e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6—Alzheimer's disease	2.52e-06	4.61e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—AKT1—Alzheimer's disease	2.48e-06	4.55e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	2.48e-06	4.53e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	2.46e-06	4.5e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	2.32e-06	4.25e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.3e-06	4.22e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	2.28e-06	4.18e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	2.25e-06	4.12e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.11e-06	3.86e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	2.08e-06	3.8e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.06e-06	1.94e-05	CbGpPWpGaD
